{
  "pmcid": "12507096",
  "sha256": "e6c4fa905d0fa12674a3bb884923285a73b82b7fb945af1abbc04a5fcdf4c3ec",
  "timestamp_utc": "2025-11-09T15:46:08.277268+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 15.575796933085503,
    "reading_ease": 13.336855250929403,
    "word_count": 269
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomly assigned to surgery with or without intraoperative molecular imaging (10:1 ratio)."
      },
      "Participants": {
        "score": 2,
        "evidence": "112 patients with suspected or biopsy-confirmed cancer in the lung scheduled for sublobar pulmonary resection"
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomly assigned to surgery with or without intraoperative molecular imaging"
      },
      "Objective": {
        "score": 1,
        "evidence": "The study objective was to determine the clinical utility of pafolacianine"
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "The primary end point was the proportion of participants with a clinically significant event"
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Participants were randomly assigned to surgery with or without intraoperative molecular imaging (10:1 ratio)."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "112 patients with suspected or biopsy-confirmed cancer in the lung"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "In 38 participants, at least 1 event was a margin 10 mm or less from the resected primary nodule (38%, 95% confidence interval, 28.5â€“48.3)"
      },
      "Harms": {
        "score": 1,
        "evidence": "No drug-related serious adverse events occurred."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 13,
    "max_score": 25
  }
}